← Evidence map

ArticleBlood cancer journal2026

Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort.

Augustin Boudry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort. | OpenQuestion